Pavel O. Bogomolov

61/2 Schepkina Str
Moscow, MOW 129110, Russian Federation

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 25 publications

Effectiveness and Safety of First-Line Empirical Eradication Therapy with Rebamipide: Results from the European Registry on Helicobacter pylori Management (Hp-EuReg).

Effectiveness and Safety of First-Line Empirical Eradication Therapy with Rebamipide: Results from the European Registry on Helicobacter pylori Management (Hp-EuReg).

Journal: Antibiotics (Basel, Switzerland)

Published: April 15, 2026

144 Weeks of bulevirtide monotherapy for chronic hepatitis D: Final and post-treatment results from a phase III randomized trial.

144 Weeks of bulevirtide monotherapy for chronic hepatitis D: Final and post-treatment results from a phase III randomized trial.

Journal: Journal of hepatology

Published: November 24, 2025

Results of a blood serum examination of residents of Moscow and the Moscow region after the end of the West Nile fever outbreak in 2021.

Results of a blood serum examination of residents of Moscow and the Moscow region after the end of the West Nile fever outbreak in 2021.

Journal: Voprosy virusologii

Published: November 14, 2025

Lack of follow-up in Helicobacter pylori eradication treatment: Results from the European registry on Helicobacter pylori management.

Lack of follow-up in Helicobacter pylori eradication treatment: Results from the European registry on Helicobacter pylori management.

Journal: World journal of gastroenterology

Published: August 29, 2025

Phase 2 Randomised Study of Bulevirtide as Monotherapy or Combined With Peg-IFNα-2a as Treatment for Chronic Hepatitis Delta.

Phase 2 Randomised Study of Bulevirtide as Monotherapy or Combined With Peg-IFNα-2a as Treatment for Chronic Hepatitis Delta.

Journal: Liver international : official journal of the International Association for the Study of the Liver

Published: August 28, 2024

Global multi-societies endorsement of the MAFLD definition.

Global multi-societies endorsement of the MAFLD definition.

Journal: Annals of hepatology

Published: August 07, 2024

Bulevirtide Combined with Pegylated Interferon for Chronic Hepatitis D.

Bulevirtide Combined with Pegylated Interferon for Chronic Hepatitis D.

Journal: The New England journal of medicine

Published: June 06, 2024

Bulevirtide Monotherapy Is Safe and Well Tolerated in Chronic Hepatitis Delta: An Integrated Safety Analysis of Bulevirtide Clinical Trials at Week 48.

Bulevirtide Monotherapy Is Safe and Well Tolerated in Chronic Hepatitis Delta: An Integrated Safety Analysis of Bulevirtide Clinical Trials at Week 48.

Journal: Liver international : official journal of the International Association for the Study of the Liver

Published: March 14, 2024

Bulevirtide monotherapy in patients with chronic HDV: Efficacy and safety results through week 96 from a phase III randomized trial.

Bulevirtide monotherapy in patients with chronic HDV: Efficacy and safety results through week 96 from a phase III randomized trial.

Journal: Journal of hepatology

Published: January 22, 2024

Use of a combination of the virus-neutralizing monoclonal antibodies casirivimab and imdevimab for mild to moderate COVID-19 in patients at high risk of progression: Results of the non-interventional observational study

Use of a combination of the virus-neutralizing monoclonal antibodies casirivimab and imdevimab for mild to moderate COVID-19 in patients at high risk of progression: Results of the non-interventional observational study

Journal: Terapevticheskii arkhiv

Published: June 29, 2023

A Phase 3, Randomized Trial of Bulevirtide in Chronic Hepatitis D.

A Phase 3, Randomized Trial of Bulevirtide in Chronic Hepatitis D.

Journal: The New England journal of medicine

Published: June 22, 2023

Role of proton pump inhibitors dosage and duration in Helicobacter pylori eradication treatment: Results from the European Registry on H. pylori management.

Role of proton pump inhibitors dosage and duration in Helicobacter pylori eradication treatment: Results from the European Registry on H. pylori management.

Journal: United European gastroenterology journal

Published: June 10, 2023

Showing 1-12 of 25

Last Updated: 09/26/2026